Taiwan Biomaterial Co., Ltd. (6649.TWO)

30.30 +0.20 (+0.66%) At close: 01:30PM CST

Taiwan Biomaterial Co., Ltd.

No. 188, Shengyi Road
1st Floor Section 1 Hsinchu County
Zhubei 30261
Taiwan
886 3 668 3088
https://www.twbm.com.tw

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Wen-Hsi Wang	General Manager	N/A	N/A	N/A
Dr. Wen-Hsiang Chang	Chief Technology Officer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Taiwan Biomaterial Co., Ltd. engages in the development and sale of medical devices in Taiwan. The company provides Foamagen, a foamy dura substitute; stroke thrombus negative pressure removal catheter system comprising suction and removal of cerebrovascular embolism blood clot for the pump system, and the nickel-titanium guidewire for guiding cerebral vascular surgery; and tissue repair and regeneration products for the treatment of early osteoarthritis. Taiwan Biomaterial Co., Ltd. Was founded in 2010 and is based in Zhubei, Taiwan.

Corporate governance

Taiwan Biomaterial Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.